Paul Ehrlich's Magic Bullets
The DOI matches its Crossref record.
Abstract
March 14, 2004, marks the 150th anniversary of the birth of Paul Ehrlich, one of the generation of pioneers who, during the 50 years that led up to World War I, laid the foundation of modern medicine. Pasteur, Röntgen, Curie, Koch, Freud, and Lister were his contemporaries in this company of trailblazers.Ehrlich's prodigious talents in the laboratory — he was called a virtuoso of test tubes — were matched by a combination of intuition and deduction that marked him as a genius. He was the father of hematology, a revolutionary immunologist, and the creator of the field of chemotherapy. . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antibody targeted drugs as cancer therapeutics
Schrama, D., Reisfeld, R. A., & Becker, J. C. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1957 · Cited by 768
Senter, P. D., & Sievers, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2289 · Cited by 763
Site-specific antibody drug conjugates for cancer therapy
Panowski, S., Bhakta, S., Raab, H., Polakis, P., & Junutula, J. R. (2014) · mAbs · doi:10.4161/mabs.27022 · Cited by 676
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Peters, C., & Brown, S. (2015) · Bioscience Reports · doi:10.1042/bsr20150089 · Cited by 492
Jain, N., Smith, S. W., Ghone, S., & Tomczuk, B. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1657-7 · Cited by 459
Antibody-Drug Conjugate-Based Therapeutics: State of the Science
Birrer, M. J., Moore, K. N., Betella, I., & Bates, R. C. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz035 · Cited by 439
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Valent, P., Groner, B., Schumacher, U., Superti-Furga, G., Busslinger, M., Kralovics, R., Zielinski, C., Penninger, J. M., Kerjaschki, D., Stingl, G., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000443526 · Cited by 409
Antibody–Drug Conjugates for Cancer Therapy
Hafeez, U., Parakh, S., Gan, H. K., & Scott, A. M. (2020) · Molecules · doi:10.3390/molecules25204764 · Cited by 395
Bosch, F., & Rosich, L. (2008) · Pharmacology · doi:10.1159/000149583 · Cited by 292
Caminade, A.-M., & Turrin, C.-O. (2014) · J. Mater. Chem. B · doi:10.1039/c4tb00171k · Cited by 290
Antibiotics: from prehistory to the present day
Gould, K. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv484 · Cited by 268
History of Antibiotics. From Salvarsan to Cephalosporins
Zaffiri, L., Gardner, J., & Toledo-Pereyra, L. H. (2012) · Journal of Investigative Surgery · doi:10.3109/08941939.2012.664099 · Cited by 260
Zhang, M., Liu, C., Tu, J., Tang, M., Ashrafizadeh, M., Nabavi, N., Sethi, G., Zhao, P., & Liu, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02305-x · Cited by 259
Khalin, I., Heimburger, D., Melnychuk, N., Collot, M., Groschup, B., Hellal, F., Reisch, A., Plesnila, N., & Klymchenko, A. S. (2020) · ACS Nano · doi:10.1021/acsnano.0c01505 · Cited by 82
Yin, X., Zhuang, Y., Song, H., Xu, Y., Zhang, F., Cui, J., Zhao, L., Yu, Y., Zhang, Q., Ye, J., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.11.002 · Cited by 9
“A typical antibody-drug conjugate (ADC) comprises a monoclonal antibody linked to a cytotoxic drug via chemical linkers to speci fi cally deliver the toxic payload to speci fi c tumor cells [1 e 4].”
Background
Metadata
- Authors
- Schwartz, R. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-11
- Volume
- 350
- Issue
- 11
- Pages
- 1079-1080
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2142844050
- Cited by
- 221
- References
- 0
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.